Cardiovascular patients' perspectives on guilt as a motivational tool
2011-04-04
(Press-News.org) New Orleans – Current research supports the notion that lifestyle choices influence cardiovascular health, but to what extent specific emotions play is undefined. Now, new research from the University of Pennsylvania School of Medicine has revealed the role that guilt may play as a motivational tool for cardiovascular patients.
Penn researchers interviewed 100 adult cardiology outpatients about the role that guilt plays in their adherence to instructions given by their physicians and as part of their views of their own health. The majority of the patients reported that guilt provides motivation to make lifestyle changes; this finding was associated with having children but no other demographics. When asked whether providers should routinely address guilt with their patients, over half of the patients said yes. Patients with a religious affiliation were more likely to answer that health practitioners should routinely address guilt.
Of the entire sample, 66 percent of patients had experienced a major cardiovascular event, such as a heart attack. Just over 20 percent of these patients reported feelings of guilt related to their health. However, half of these patients wished they had taken better care of themselves, but had no feelings of guilt relating to their health. The study results were reported at the 2011 American College of Cardiology meeting in New Orleans.
"When counseling cardiovascular patients about lifestyle, practitioners should consider addressing guilt as both a motivation for, and a barrier to, lifestyle change, particularly in patients with religious backgrounds," concluded senior author James Kirkpatrick, MD, assistant professor of Medicine, Cardiovascular Medicine Division at Penn. "Further research is needed to explore the impact of guilt motivation on patient outcomes."
###
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4 billion enterprise.
Penn's School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools and among the top 10 schools for primary care. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $507.6 million awarded in the 2010 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania â€" recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2010, Penn Medicine provided $788 million to benefit our community.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-04-04
Underground Elephant has pledged to donate $50,000 over the next year to the American Red Cross Japan Earthquake and Pacific Tsunami Fund. The donation will support the relief efforts for survivors who have been affected by the earthquake and tsunami in Japan.
"The impact of the earthquake and tsunami's devastation on the people in Japan is unconscionable," said Jason Kulpa, CEO of Underground Elephant. "All of us at Underground Elephant are deeply moved by the tremendous global support that Japan is receiving and hope that our donation will further assist relief efforts."
Underground ...
2011-04-04
Orlando, Fla. -- In mice models of breast cancer, researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, found that vitamin D significantly reduced development of estrogen receptor-positive (ER+) breast cancer both in lean and obese mice, but had no beneficial effect in estrogen receptor-negative (ER-) cancer. In fact, obese mice destined to develop ER- breast cancer were clearly worse off than lean ER- mice if they were given vitamin D in their diet.
The researchers, who will present their study at the American ...
2011-04-04
"I know a girl. She loves a girl. She is her world. She always hides the tears that she cries. Baby don't hide. If you disagree then just let them be," proclaims "Let Her Love Her," the second single off of rising neo-soul/pop band, Sweet Leda's recently-released album, Need the Music.
The song challenges prejudices and anti-gay sentiments by asserting that love is love. "Imagine if you finally found the right person, and you weren't even allowed to marry that person! Even worse, imagine that some people protested against you and demonstrated hate simply because of ...
2011-04-04
Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, based on a scientific paper that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.
With ICM, the left ventricle of the patient's heart pumps blood poorly due to coronary artery disease. With DCM, the heart has become weakened and enlarged, and cannot pump blood efficiently. ...
2011-04-04
Ranolazine (Ranexa, Gilead) is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.
Patients with refractory angina, who have chronic chest pain but are not candidates for revascularization, have limited therapeutic options and significant limitations in their quality of life, the study authors wrote. Conversely, patients with chronic angina ...
2011-04-04
Each of the 400 students at Hartford Public High School Engineering and Green Technology Academy received a key to success in the form a DISC Behavioral and Workplace Motivator Assessment courtesy of Bill Bonnstetter, CEO and founder of TTI Performance Systems, Ltd. in Scottsdale, AZ and John Birch, founder and president of The Birch Group, LLC, a management consultant firm based in New Britain, CT. TTI Performance Systems generously provided the assessments and The Birch Group administered and coordinated the reports as well as provided training to the students. The value ...
2011-04-04
The implementation of acute heart attack or ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing orders in Minnesota community hospitals without cardiac catheterization labs has dramatically improved since 2003, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.
Since the 1990s, the American College Cardiology (ACC)/American Heart Association (AHA) STEMI guidelines recommended that all hospitals develop protocols and standing orders (reperfusion strategy, ...
2011-04-04
ORLANDO, Fla. — A panel of biomarkers appears to be able to identify the presence of lung cancer in the blood samples of people who have never smoked, according to data presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
While lung cancer has long been linked to smoking, approximately one-fourth of patients with lung cancer have never smoked. Researchers are working on ways to identify the presence of lung cancer in these patients.
Charlie Birse, Ph.D., associate director of product development at Celera Corporation, and colleagues are investigating ...
2011-04-04
ORLANDO, Fla. — Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
In a blinded test performed under the auspices of the National Cancer Institute's Early Detection Research Network Biomarker Discovery Lab, the proteomic assay could detect 15 of 19 cases of malignant pleural mesothelioma that were in stage 1 or stage 2, making the test about ...
2011-04-04
ORLANDO, Fla. — Breast cancer risk can be assessed by examining the epithelial cells found in breast milk, according to preliminary study results presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
This screening method has the potential to provide a personalized assessment of breast cancer risk, said lead researcher Kathleen F. Arcaro, Ph.D., associate professor of veterinary and animal sciences at the University of Massachusetts Amherst. Given that roughly 80 percent of women give birth, this screen would also cover a large percentage of the female population. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Cardiovascular patients' perspectives on guilt as a motivational tool
